Short Interest in EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Increases By 4,525.3%

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 192,041 shares, a growth of 4,525.3% from the May 31st total of 4,152 shares. Based on an average trading volume of 331,947 shares, the short-interest ratio is presently 0.6 days. Approximately 0.0% of the shares of the company are short sold.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft assumed coverage on EssilorLuxottica in a report on Tuesday, May 12th. They set a “hold” rating for the company. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

EssilorLuxottica Price Performance

ESLOY stock traded up $1.22 during midday trading on Friday, hitting $95.68. The stock had a trading volume of 251,541 shares, compared to its average volume of 144,926. EssilorLuxottica has a 52 week low of $93.42 and a 52 week high of $186.81. The stock has a 50-day simple moving average of $103.91 and a 200 day simple moving average of $128.68. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.